Why We Oppose Golden Rice
By The Stop Golden Rice Network,
Independent Science News
| 08. 07. 2020
Released on the 7th annual International Day of Protest Against Golden Rice
The push for corporate-led solutions to hunger and malnutrition is alarming. In particular, Golden Rice is now being proposed as a solution to the worsening hunger and malnutrition associated with the pandemic. Agrochemical transnationals (TNCs) and collaborating institutions such as the International Rice Research Institute (IRRI) are using concerns over food security during the pandemic to push for an industrial agricultural system that is already discredited. To quote PAN Asia Pacific:
“in the webinar “The future of food systems in Southeast Asia post-COVID19” organised by IRRI and the FAO, Jean Balie, IRRI’s head of Agri-Food Policy, said that they are “looking to increase the mineral and vitamin content in rice grains” as a response to the pandemic, alluding to renewed promotion of the genetically-modified Golden Rice, which has recently been approved for commercialization in Bangladesh and the Philippines” said PANAP.
Golden Rice projects and applications are currently underway in three countries. On December 10, 2019, the Philippines’ Dept. of Agriculture’s Bureau of Plant Industry (DA-BPI) issued a Golden Rice permit for Direct Use for Food, Feed and...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...